IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Sudeep Pharma Ltd.
Issue Open Date 21-Nov-25  
Issue Closing Date 25-Nov-25  
Application Money 100  
Allotment Money  
Price Band 563 - 593  
Minimium Application No. 25  
Issue Size (Shares) 10564926  
Market Lot 1.00  
Objective
(i)Capital expenditure towards procurement of machinery for our production line located at Nandesari Facility I; and(ii)General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   2263913   264240450   116.72  
Qualified Institutional Buyers   3018550   643188450   213.08  
Retail Individual Investors   5282463   82671250   15.65  
Business Description
We are a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and are dedicated to contributing to the global healthcare ecosystem. We leverage our inhouse developed technologies for processe
more...
Promoter's Holding
Total Share Capital   99503523  
Offered to Public   10564926  
Promoter's Holding (Pre-Issue)   89.37  
Promoter's Holding (Post-Issue)   76.15  
Address
129/1/ A
G. I. D. C. Estate
Nandesari

Vadodara ,
Gujarat ,
391340
Phone: 0265 284 0656/329 1354
Email: cs.sudeep@sudeepgroup.com
Website: https://www.sudeeppharma.com
Registrar
MUFG Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
BSE, NSE
Lead Manager
ICICI Securities Ltd
IIFL Capital Services Ltd.
Promoters
Avani Sujit Bhayani
Bhayani Family Trust
Riva Resources Pvt Ltd.
Shanil Sujit Bhayani
Sujeet Jaysukh Bhayani HUF
Sujit Jaysukh Bhayani
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.